Funded by the Innovative Medicines Initiative 2 Joint Undertaking (IMI 2 JU), ECRAID is the working title of the envisaged European wide sustainable clinical research network for infectious diseases, that is to emerge from the PREPARE and COMBACTE projects. This new organization should generate complementary sustainable sources of income, ensuring the long-term continuity of its activities and produce rigorous, innovative, world-leading research that helps protect the people Europe from Antimicrobial resistance (AMR) and Emerging Infectious diseases (EID) threats over the long term.

On the 17th of January, the kick-off meeting aims to bring together global networks and key stakeholders to constructively discuss ECRAID and its sustainable solutions to protect Europe from AMR and EID threats.